<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005214</url>
  </required_header>
  <id_info>
    <org_study_id>1093</org_study_id>
    <nct_id>NCT00005214</nct_id>
  </id_info>
  <brief_title>Epidemiology of Genetic Factors in Lipid Metabolism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To investigate the genetics and epidemiology of fasting and postprandial lipid, lipoprotein,
      and apolipoprotein levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Altered plasma lipid, lipoprotein, and apolipoprotein levels are associated with the
      occurrence of coronary heart disease, non-insulin dependent diabetes, and gallbladder
      disease. Although there are many other environmental and biological correlates, clinical,
      epidemiological, and experimental lines of evidence indicate that lipid metabolism has a
      central role in the development of coronary heart disease. Evidence pointing to the
      association between measures of lipid metabolism and other chronic diseases is no less
      compelling. Non-insulin dependent diabetes mellitus exhibits both the diagnostic abnormal
      carbohydrate utilization, and altered lipid metabolism. The hypothesis that abnormal lipid
      metabolism may be causally involved in gallbladder disease is suggested by the presence of
      cholesterol saturated bile several years prior to the onset of clinically definable
      gallstones.

      Biometrical genetic studies have established that a significant proportion of the fasting
      plasma lipid, lipoprotein, and apolipoprotein levels is attributable to genetic differences
      among individuals. Although these studies indicate that polygenetic variability is
      contributing, they do not yield information about specific candidate genes whose products are
      involved in the metabolism of the phenotype of interest. Recent advances in molecular biology
      enable one to measure genetic variability at candidate loci for several risk factors for the
      common chronic diseases. With this information the contribution of specific candidate genes
      to polygenetic and phenotypic variability can be estimated. Estimating the effects of
      specific candidate loci will facilitate the investigation of the interaction between genetic
      and environmental factors. This study focussed on restriction fragment length polymorphisms
      in and around the apolipoprotein B gene and on the apolipoprotein E protein polymorphism. The
      apolipoprotein B and apolipoprotein E genes were selected because of their central role in
      lipid metabolism and interaction with dietary factors.

      DESIGN NARRATIVE:

      Using data and blood samples from the 75 nuclear families of Nancy, a determination was made
      of the effects of apolipoprotein B and E genes on fasting levels of total cholesterol and
      triglycerides, LDL-cholesterol, HDL-cholesterol, HDL2-cholesterol, HDL3-cholesterol, apo A-I,
      apo-B, apo C-III, and apo-E. Genetic variability was directly assessed by DNA restriction
      site variability in the apolipoprotein B gene and by measuring the apolipoprotein E
      polymorphism. Data collected from these families permitted the partitioning of the effects of
      the apolipoprotein B and E genes from the overall polygenetic and phenotypic variance of the
      measured lipids, lipoproteins, and apolipoproteins.

      Fasting and postprandial lipids, lipoproteins, and apolipoproteins were obtained from 100
      Mexican-American women. A determination was made of the effects of apolipoprotein E and B
      genes, disease status, age, and their interactions on fasting and postprandial lipid
      metabolism.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1988</start_date>
  <completion_date>March 1993</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Atherosclerosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):941-7.</citation>
    <PMID>8696957</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Xiong WJ, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc Natl Acad Sci U S A. 1989 Jan;86(1):212-6.</citation>
    <PMID>2911570</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Chan L. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction. Nucleic Acids Res. 1989 May 25;17(10):4003.</citation>
    <PMID>2567503</PMID>
  </reference>
  <reference>
    <citation>Gueguen R, Visvikis S, Steinmetz J, Siest G, Boerwinkle E. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet. 1989 Nov;45(5):793-802.</citation>
    <PMID>2816943</PMID>
  </reference>
  <reference>
    <citation>Visvikis S, Chan L, Siest G, Drouin P, Boerwinkle E. An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet. 1990 Mar;84(4):373-5.</citation>
    <PMID>2307462</PMID>
  </reference>
  <reference>
    <citation>Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990 May 24;322(21):1494-9.</citation>
    <PMID>2139920</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Lee SS, Butler R, Schumaker VN, Chan L. Rapid typing of apolipoprotein B DNA polymorphisms by DNA amplification. Association between Ag epitopes of human apolipoprotein B-100, a signal peptide insertion/deletion polymorphism, and a 3'flanking DNA variable number of tandem repeats polymorphism of the apolipoprotein B gene. Atherosclerosis. 1990 Apr;81(3):225-32.</citation>
    <PMID>1693506</PMID>
  </reference>
  <reference>
    <citation>Visvikis S, Steinmetz J, Boerwinkle E, Gueguen R, Galteau MM, Siest G. Frequency and effects of the apolipoprotein A-IV polymorphism. Clin Genet. 1990 Jun;37(6):435-41.</citation>
    <PMID>2383930</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Visvikis S, Chan L. Two polymorphisms for amino acid substitutions in the APOA4 gene. Nucleic Acids Res. 1990 Aug 25;18(16):4966.</citation>
    <PMID>2395672</PMID>
  </reference>
  <reference>
    <citation>de Temmerman P, Visvikis S, Boerwinkle E, Siest G. Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region. Nucleic Acids Res. 1990 Sep 25;18(18):5576.</citation>
    <PMID>2216752</PMID>
  </reference>
  <reference>
    <citation>Xu CF, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE, Talmud PJ. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol. 1990;7(4):261-75.</citation>
    <PMID>1977654</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Hanis CL, Chan L. A unique length polymorphism in the signal peptide region of the apolipoprotein B gene in Mexican-Americans. Nucleic Acids Res. 1990 Dec 11;18(23):7193.</citation>
    <PMID>2263508</PMID>
  </reference>
  <reference>
    <citation>Talmud PJ, Boerwinkle E, Xu CF, Tikkanen MJ, Pietinen P, Huttunen JK, Humphries S. Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol. 1992;9(4):249-60.</citation>
    <PMID>1356882</PMID>
  </reference>
  <reference>
    <citation>Shriver MD, Siest G, Boerwinkle E. Length and sequence variation in the apolipoprotein B intron 20 Alu repeat. Genomics. 1992 Oct;14(2):449-54.</citation>
    <PMID>1427859</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992 Jul;90(1):52-60.</citation>
    <PMID>1386087</PMID>
  </reference>
  <reference>
    <citation>Fornage M, Chan L, Siest G, Boerwinkle E. Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics. 1992 Jan;12(1):63-8.</citation>
    <PMID>1733865</PMID>
  </reference>
  <reference>
    <citation>Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991 Jun;87(6):2153-61. Erratum in: J Clin Invest 1991 Aug;88(2):723.</citation>
    <PMID>1645755</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr, Patsch W. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet. 1991 Dec;49(6):1145-54.</citation>
    <PMID>1746549</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Chen SH, Visvikis S, Hanis CL, Siest G, Chan L. Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels. Diabetes. 1991 Nov;40(11):1539-44.</citation>
    <PMID>1936612</PMID>
  </reference>
  <reference>
    <citation>Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csázár A, Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991 Aug;49(2):338-49.</citation>
    <PMID>1867194</PMID>
  </reference>
  <reference>
    <citation>Mancini FP, Mooser V, Guerra R, Hobbs HH. Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. Hum Mol Genet. 1995 Sep;4(9):1535-42.</citation>
    <PMID>8541836</PMID>
  </reference>
  <reference>
    <citation>Carrejo MH, Sharrett R, Patsch W, Boerwinkle E. No association of apolipoprotein A-IV codon 347 and 360 variation with atherosclerosis and lipid transport in a sample of mixed hyperlipidemics. Genet Epidemiol. 1995;12(4):371-80.</citation>
    <PMID>8536954</PMID>
  </reference>
  <reference>
    <citation>Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E, Hillis LD, Hobbs HH. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):850-5.</citation>
    <PMID>7600116</PMID>
  </reference>
  <reference>
    <citation>de Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet. 1995 Jun;56(6):1379-90.</citation>
    <PMID>7762561</PMID>
  </reference>
  <reference>
    <citation>Hallman DM, Visvikis S, Steinmetz J, Boerwinkle E. The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis. Ann Hum Genet. 1994 Jan;58(Pt 1):35-64.</citation>
    <PMID>8031014</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet. 1994 Feb;54(2):341-60.</citation>
    <PMID>8304350</PMID>
  </reference>
  <reference>
    <citation>Moliterno DJ, Lange RA, Meidell RS, Willard JE, Leffert CC, Gerard RD, Boerwinkle E, Hobbs HH, Hillis LD. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation. 1993 Sep;88(3):935-40.</citation>
    <PMID>8353920</PMID>
  </reference>
  <verification_date>May 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

